2 results
Approved WMOPending
Determining the effectiveness of commonly used premedicating agents in reducing subclinical stress responses in newborns during intubation.
Approved WMOCompleted
The primary objective is to evaluate the efficacy of daratumumab in addition to standard chemotherapy in relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) and T-cell ALL as measured by the complete response (CR) rate.The secondary…